If there is one thing we need to do, it is to cure obesity so the generations that follow don't have shorter lifespans than previous generations.
Unfortunately, obesity rates have doubled in the last 20 years. Without changes, 50% of the adult population will be obese by 2030.
To address the challenges, science has brought us new medications - not all of them successful and more than a few with severe side effects. While medications come and go, complications associated with surgery and diets have come and stayed.
However, thanks to phenotyping, we can better understand the unique genetics, microbiome, and metabolism of individuals. Phenotyping enables us to understand the type of obesity disease people have and tailor treatments that address it specifically.
The groundbreaking technology from Phenomix Sciences is rooted in hard science from Mayo Clinic. We're committed to advancing the understanding of obesity treatment through.
We believe knowledge is power, and the ability to diagnose and treat patients with the right, the right , or the right will be a major step forward for curing obesity.
Today, diet and exercise help people with obesity lose approximately 5% of their total body weight. Adding medication increases the amount of weight patients lose; however it is difficult to know which patients will respond to each specific medication. Obesity phenotyping has been shown to identify patients who will respond to the medication prescribed. In so doing, patients achieved 2x greater weight loss than those who were not phenotyped, according to the Mayo Clinic study.